TBPH
Theravance Biopharma, Inc.
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Fund move
Fund move
Last report0 of 8 at or beyond impliedshaded = implied▲▼ = realized× = |realized| ÷ implied
−0.12%
vs ±6.0% implied · ×0.02
shaded = implied · ▲▼ = realized
No thesis.
Linked news
| Rank | Manager | Value | % 13F | ||
|---|---|---|---|---|---|
| 1 | Madison Avenue PartnersMadison Avenue Partners | $156.6M | 19.13% | −3.14% | |
| 2 | Weiss Asset ManagementWeiss | $126.8M | 15.49% | 0.00% | |
| 3 | BlackRockBlackRockindex-like | $77.6M | 9.47% | +6.20% | |
| 4 | Newtyn ManagementNewtyn | $58.4M | 7.13% | −29.07% | |
| 5 | Irenic Capital ManagementIrenic | $46.9M | 5.73% | 0.00% | |
| 6 | Vanguard Capital ManagementVanguardindex-like | $30.1M | 3.68% | −0.69% | |
| 7 | State StreetState Streetindex-like | $22.6M | 2.76% | +2.41% | |
| 8 | Two Sigma InvestmentsTwo Sigma | $20.8M | 2.55% | −2.62% | |
| 9 | D. E. ShawD. E. Shaw | $20.2M | 2.46% | +24.25% | |
| 10 | Acadian Asset ManagementAcadian | $20.0M | 2.44% | −7.96% | |
| 11 | Geode Capital ManagementGeodeindex-like | $19.0M | 2.32% | −1.72% | |
| 12 | Dimensional Fund AdvisorsDimensional | $17.7M | 2.17% | +6.04% | |
| 13 | Mackenzie FinancialMackenzie Financial | $16.8M | 2.05% | +296.43% | |
| 14 | Morgan StanleyMorgan Stanley | $12.0M | 1.46% | +38.20% | |
| 15 | Oasis ManagementOasis | $9.9M | 1.21% | 0.00% | |
| 16 | Citadel AdvisorsCitadel | $9.1M | 1.12% | +354.75% | |
| 17 | UBS GroupUBS | $8.3M | 1.01% | −36.09% | |
| 18 | Qube Research & TechnologiesQube Research & Technologies | $7.3M | 0.89% | +48.48% | |
| 19 | Northern TrustNorthern Trustindex-like | $6.9M | 0.84% | +9.13% | |
| 20 | Vanguard Portfolio ManagementVanguard Portfolioindex-like | $6.7M | 0.82% | −1.65% | |
| 21 | Jupiter TopcoJupiter Topco | $6.6M | 0.80% | — | |
| 22 | Goldman Sachs GroupGoldman Sachs | $5.8M | 0.71% | −18.31% | |
| 23 | Charles Schwab Investment ManagementCharles Schwabindex-like | $5.5M | 0.67% | +3.40% | |
| 24 | Glazer CapitalGlazer Capital | $5.1M | 0.63% | new | |
| 25 | Vanguard Fiduciary TrustVanguard Fiduciary Trustindex-like | $4.6M | 0.57% | +3.88% |
175 managers report $818.6M of Theravance Biopharma on form 13F for the quarter ended Jun 30 '26. 15 of them hold 80% of it; Madison Avenue Partners is largest at 19.13%.
Theravance Biopharma, Inc.
17.03
0.00 · +0.02%
post 17.04 +0.04%
No implied move.
No implied move.
Expected move
No implied move.